David Green

5.4k total citations · 1 hit paper
80 papers, 3.1k citations indexed

About

David Green is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, David Green has authored 80 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cardiology and Cardiovascular Medicine, 26 papers in Internal Medicine and 24 papers in Surgery. Recurrent topics in David Green's work include Venous Thromboembolism Diagnosis and Management (26 papers), Atrial Fibrillation Management and Outcomes (19 papers) and Cardiac, Anesthesia and Surgical Outcomes (10 papers). David Green is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (26 papers), Atrial Fibrillation Management and Outcomes (19 papers) and Cardiac, Anesthesia and Surgical Outcomes (10 papers). David Green collaborates with scholars based in United States, Australia and United Kingdom. David Green's co-authors include Gary E. Raskob, David Rosenbloom, Russell D. Hull, Akbar Panju, Rollin Brant, Graham F. Pineo, Gary J. Martin, Jeffrey S. Ginsberg, Patrick Brill-Edwards and Jack Hirsh and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

David Green

76 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis

1992 544 citations Russell D. Hull, Gary E. Raskob et al. profile →

Peers

Countries citing papers authored by David Green

Since Specialization

Citations

This map shows the geographic impact of David Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Green more than expected).

Fields of papers citing papers by David Green

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Green. The network helps show where David Green may publish in the future.

Co-authorship network of co-authors of David Green

This figure shows the co-authorship network connecting the top 25 collaborators of David Green. A scholar is included among the top collaborators of David Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Green. David Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anticoagulant prescribing patterns in patients with primary central nervous system malignancies and secondary metastases 2024 ·Journal of Thrombosis and Thrombolysis ·(unknown), Tania Ahuja, (unknown), (unknown), John Papadopoulos, David Green, (unknown)	1
2	To Measure or Not to Measure: Direct Oral Anticoagulant Laboratory Assay Monitoring in Clinical Practice 2023 ·Advances in Hematology ·Tania Ahuja, (unknown), (unknown), David Green	6
3	Perils of Antithrombotic Transitions: Effect of Oral Factor Xa Inhibitors on the Heparin Antifactor Xa Assay 2020 ·Therapeutic Drug Monitoring ·Tania Ahuja, Irene Yang, (unknown), John Papadopoulos, David Green	1
4	Assessment of patients post reversal with idarucizumab 2018 ·Journal of Thrombosis and Thrombolysis ·(unknown), Tania Ahuja, David Green	8
5	Anticoagulation prescribing patterns in patients with cancer 2017 ·Journal of Thrombosis and Thrombolysis ·(unknown), Tania Ahuja, (unknown), (unknown), David Green, John Papadopoulos	19
6	Limb Gangrene in Cancer Patients Receiving Warfarin 2015 ·Journal watch ·David Green	1
7	Antidote to Dabigatran Is Approved 2015 ·Journal watch ·David Green	1
8	Using bispectral index and cerebral oximetry to guide hemodynamic therapy in high-risk surgical patients 2013 ·Perioperative Medicine ·Heena Bidd, (unknown), David Green	17
9	Glucose-Insulin-Potassium Reduces the Incidence of Low Cardiac Output Episodes After Aortic Valve Replacement for Aortic Stenosis in Patients With Left Ventricular Hypertrophy 2011 ·Circulation ·Neil Howell, Houman Ashrafian, Nigel E Drury, (unknown), Hussain Contractor, Henrik Isackson, Melanie Calvert, Lynne Williams, Nick Freemantle, (unknown), David Green, Michael Frenneaux, Robert S. Bonser, Jorge Mascaro, Timothy R. Graham, Stephen J. Rooney, Ian C. Wilson, Duilio Pagano	49
10	Latest developments in peri-operative monitoring of the high-risk major surgery patient 2010 ·International Journal of Surgery ·David Green, (unknown)	28
11	Elevated fibrinogen levels and subsequent subclinical atherosclerosis: The CARDIA Study 2008 ·Atherosclerosis ·David Green, Nancy Foiles, Cheeling Chan, Pamela J. Schreiner, Kiang Liu	99
12	Management of Bleeding Complications of Hematologic Malignancies 2007 ·Seminars in Thrombosis and Hemostasis ·David Green	16
13	Bivalirudin for Acute Coronary Syndromes 2006 ·Journal watch ·David Green	0
14	Importance of cutaneous cooling during photothermal epilation: Theoretical and practical considerations 2002 ·Lasers in Surgery and Medicine ·(unknown), David Green	20
15	Removal of periocular veins by sclerotherapy 2001 ·Ophthalmology ·David Green	18
16	Subcutaneous Low-Molecular-Weight Heparin Compared With Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis 1992 ·Obstetrical & Gynecological Survey ·Russell D. Hull, Gary E. Raskob, Graham F. Pineo, David Green, Arthur A. Trowbridge, (unknown), Robert G. Lerner, Jack Hall, Terence G. Sparling, (unknown), (unknown), (unknown), (unknown), Geno J. Merli, John F. Ward, (unknown), David Rosenbloom, Rollin Brant	48
17	Autoerythrocyte sensitization syndrome (psychogenic purpura) 1992 ·Journal of the American Academy of Dermatology ·David A. Berman, Henry H. Roenigk, David Green	13
18	Prevention of Thromboembolism after Spinal Cord Injury Using Low-Molecular-Weight Heparin 1990 ·Annals of Internal Medicine ·David Green, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	160
19	Erythema Multiforme and Stevens-Johnson Syndrome 1990 ·CHEST Journal ·Roy Patterson, Mark S. Dykewicz, (unknown), Leslie C. Grammer, David Green, Paul A. Greenberger, Kris G. McGrath, Cheryl L. Walker	40
20	Early supradiaphragmatic hodgkin's disease: High-dose gallium scanning obviates the need for staging laparotomy 1986 ·Cancer ·(unknown), Douglas Joshua, H. Kronenberg, Andrew F. McLaughlin, David Green, James R. May	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact